Professional Documents
Culture Documents
Cliff Murphy
Partner ~ ConAlliance UK
Interim CEO at NIGHTINGALE EOS
Presentation Overview
Introduction & changing nature of healthcare
What is value?
A company lifecycle
A buyers perspective ~ Trade sale
Other exit strategies ~ IPO & Private Exit
Top tips for value
FOUNDED
2011
HEADQUARTERS
OFFICES
CONALLIANCE
TEAM
Currently 15 people:
Experienced senior professionals from management consulting
firms, investment banks and healthcare companies with indepth insight into the life sciences markets, strong research
and clinical foundations.
INDUSTRY
SPECIALIZATION
EXPERIENCE
CLIENTS
What we do
Work on the Buyside & Sell
side
Work with small companies
on the commercialisation of
technology
Strategically place
technology
Prepare companies for sale
Divestures
Medical technology
40%
Restructuring and
fincance
5%
20%
45%
Hospital care
Acquisitions
Life Sciences
30%
Sector Split
Expertise
25%
35%
Presentation Overview
Introduction & changing nature of healthcare
What is value?
A company lifecycle
A buyers perspective ~ Trade sale
Other exit strategies ~ IPO & Private Exit
Top tips for value
Proposition: methodology /
technology
Value Proposition
Med tech &
consumables
Diagnosis
Intervention /
therapy
Treatment/follow
up
Presentation Overview
Introduction & changing nature of healthcare
What is value?
A company lifecycle
A buyers perspective ~ Trade Sale
Other exit strategies ~ IPO & Private Exit
Top tips for value
Company Revenues
Risk
PE
Friends &
family ~ Angel
time
VC
IPO
Value Creation
Reimbursement is
crucial to value
creation
Concept
Prototype
Clinical
Reg
trials approval
Early
commercial
Full
commercial
Presentation Overview
Introduction & changing nature of healthcare
What is value?
A company lifecycle
A buyers perspective ~ Trade Sale
Other exit strategies ~ IPO & Private Exit
Top tips for value
Benefits:
Technology play
Revenue and Synergy play
Relatively clean
Less demanding than an IPO in terms
of cost or resource
Down side:
You are out of the business!
Little control over the longer term
Corporate strategy: The quest for parenting advantage
Alignment
Integration
Clean books
Ownership
structure
Small Co.
prescriptive
IP
Future
Proofing
FTO
Competitor
Synergy
Technology
Presentation Overview
Introduction & changing nature of healthcare
What is value?
A company lifecycle
A buyers perspective ~ Trade sale
Other exit strategies ~ IPO & Private Exit
Top tips for value
Corporate Loans
Company Revenues
Risk
PE
Friends &
family ~
Angel
time
VC
Why IPO?
Greater access to funds
Access to alternative funds
Enhances prestige
Higher valuations than private companies
Potential exit of investors
IPO
Corporate Loans
Company Revenues
Risk
PE
Friends &
family ~
Angel
time
VC
IPO
Presentation Overview
Introduction & changing nature of healthcare
What is value?
A company lifecycle
A buyers perspective ~ Trade sale
Other exit strategies ~ IPO & Private Exit
Top tips for value
Understand what you are getting into and find an Buy the ticket take the ride